Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Molecular & Cellular Proteomics · 2023-10 · 22 (10) · 100629
DOI: 10.1016/j.mcpro.2023.100629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023-10. Verfasst von Charlotte E Teunissen und 31 weiteren Autor:innen. Beteiligte Einrichtung: MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; Neurochemistry Lab, …. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Neurodegenerative dementias are progressive diseases that cause neuronal network breakdown in different brain regions often because of accumulation of misfolded proteins in the brain extracellular matrix, such as amyloids or inside neurons or other cell types of the brain. Several diagnostic protein biomarkers in body fluids are being used and implemented, such as for Alzheimer's disease. However, there is still a lack of biomarkers for co-pathologies and other causes of dementia. Such biofluid-based biomarkers enable precision medicine approaches for diagnosis and treatment, allow to learn more about underlying disease processes, and facilitate the development of patient inclusion and evaluation tools in clinical trials. When designing studies to discover novel biofluid-based biomarkers, choice of technology is an important starting point. But there are so many technologies to choose among. To address this, we here review the technologies that are currently available in research settings and, in some cases, in clinical laboratory practice. This presents a form of lexicon on each technology addressing its use in research and clinics, its strengths and limitations, and a future perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; Neurochemistry Lab, Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam U…
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; KIN Center for Digital Innovation, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Lux…
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; National Measurement Laboratory at LGC, Teddington, United Kingdom.
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; ADx NeuroSciences, Gent, Belgium.
- MIRIADE Consortium, Multiomics Interdisciplinary Research Integration to Address DEmentia diagnosis, Amsterdam, The Netherlands; Department of Computer Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Förderung
- Horizon 2020
- EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions
Zitieren
APA
Teunissen, C. E., Kimble, L., Bayoumy, S., Bolsewig, K., Burtscher, F., Coppens, S., Das, S., Gogishvili, D., Fernandes Gomes, B., Gómez de San José, N., Mavrina, E., Meda, F. J., Mohaupt, P., Mravinacová, S., Waury, K., Wojdała, A. L., Abeln, S., Chiasserini, D., Hirtz, C., …, & MIRIADE consortium (2023). Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. Molecular & Cellular Proteomics, 22(10), 100629. https://doi.org/10.1016/j.mcpro.2023.100629
Vancouver
Teunissen CE, Kimble L, Bayoumy S, Bolsewig K, Burtscher F, Coppens S, et al. Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. Molecular & Cellular Proteomics. 2023;22(10):100629. doi:10.1016/j.mcpro.2023.100629
BibTeX
@article{Teunissen2023,
author = {Teunissen, Charlotte E and Kimble, Leighann and Bayoumy, Sherif and Bolsewig, Katharina and Burtscher, Felicia and Coppens, Salomé and Das, Shreyasee and Gogishvili, Dea and Fernandes Gomes, Bárbara and Gómez de San José, Nerea and Mavrina, Ekaterina and Meda, Francisco J and Mohaupt, Pablo and Mravinacová, Sára and Waury, Katharina and Wojdała, Anna Lidia and Abeln, Sanne and Chiasserini, Davide and Hirtz, Christophe and Gaetani, Lorenzo and Vermunt, Lisa and Bellomo, Giovanni and Halbgebauer, Steffen and Lehmann, Sylvain and Månberg, Anna and Nilsson, Peter and Otto, Markus and Vanmechelen, Eugeen and Verberk, Inge M W and Willemse, Eline and Zetterberg, Henrik and MIRIADE consortium, MIRIADE consortium},
title = {Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias},
journal = {Molecular & Cellular Proteomics},
year = {2023},
volume = {22},
number = {10},
pages = {100629},
doi = {10.1016/j.mcpro.2023.100629}
}
EUVIMED